The Melanoma Nursing Initiative – Home Forums Immunotherapy Other Pembro plus Epacadostat Reply To: Pembro plus Epacadostat

#4819
Expert Nurse
Lisa Kottschade

The results of this trial were quite striking, especially with strong Phase I/II data. There is some thought that the dose of the IDO inhibitor may have been too low. Was very disappointing as this may have been a good alternative to dual ICI therapy in those that tolerability was questionable.